MedPath

study of Amavata and to asses the therapeutic efficacy of shunthi churna on Rheumatoid arthritis.

Not yet recruiting
Conditions
Diseases of the musculoskeletal system and connective tissue. Ayurveda Condition: AMAVATAH,
Registration Number
CTRI/2021/11/038320
Lead Sponsor
Goverment Ayurvedic college patna
Brief Summary

The disease Amavata is a one amongst them which have causative factors as described in Ayurvedic text are sedentary habits, incompatible diet and regimen, physical exercise etc, According to the Ayurvedic texts the Amavata is a disease of rasavaha srotas and mandagni is an important contributing factor in its pathogenesis. In modern science the aetiopathology of the disease is not very clear, whereas in Ayurvedic text a set of aetiological factors are mentioned.Chronic condition may cause debility, deformitites of joints and crippling, unfortunately due to unknown aetiology there is no effective treatment is availavable in modern science. Shunthi is a well known drug having vatakaphahara properties and due to katu rasa, ushna veerya it is used in mandagni.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
30
Inclusion Criteria
  • The sign and symptom based on both Ayurvedic as well as modern view.
  • Classical symptoms of rheumatoid arthritis have diagnose on basis of ACR criteria.
Exclusion Criteria
  • Immunocompromised patients.
  • Severe deformities Any complication e.g. Diabetes Mellitus, Tuberculosis etc.
  • Pregnant and lactating women not included in the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CUREcure
Secondary Outcome Measures
NameTimeMethod
CureCure

Trial Locations

Locations (1)

Goverment Ayurvedic college Patna

🇮🇳

Patna, BIHAR, India

Goverment Ayurvedic college Patna
🇮🇳Patna, BIHAR, India
Dr vinod singh
Principal investigator
7579453202
vinodtitiyal2017@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.